Cubist Systematic Strategies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-72,546
| Closed | -$2.97M | – | 2423 |
|
|
2024
Q2 | $2.97M | Buy |
72,546
+46,473
| +178% | +$1.9M | 0.02% | 470 |
|
|
2024
Q1 | $1.1M | Sell |
26,073
-28,902
| -53% | -$1.22M | 0.01% | 1102 |
|
|
2023
Q4 | $2.33M | Buy |
+54,975
| New | +$2.33M | 0.02% | 761 |
|
|
2023
Q1 | – | Sell |
-6,085
| Closed | -$192K | – | 3394 |
|
|
2022
Q4 | $192K | Sell |
6,085
-27,122
| -82% | -$855K | ﹤0.01% | 2659 |
|
|
2022
Q3 | $938K | Buy |
+33,207
| New | +$938K | 0.01% | 2115 |
|
|
2022
Q1 | – | Sell |
-8,486
| Closed | -$275K | – | 3825 |
|
|
2021
Q4 | $275K | Sell |
8,486
-9,323
| -52% | -$302K | ﹤0.01% | 2854 |
|
|
2021
Q3 | $525K | Buy |
17,809
+17,709
| +17,709% | +$522K | 0.01% | 2004 |
|
|
2021
Q2 | $3K | Sell |
100
-300
| -75% | -$9K | ﹤0.01% | 2885 |
|
|
2021
Q1 | $5K | Sell |
400
-11,725
| -97% | -$147K | ﹤0.01% | 2789 |
|
|
2020
Q4 | $201K | Buy |
+12,125
| New | +$201K | ﹤0.01% | 2237 |
|